SANTA CLARA, Calif., Sept. 15, 2005 (PRIMEZONE) -- The Dr. Rath Research Institute applauded the findings of Dr. Mark Levine and colleagues at the U.S. National Institutes of Health, which show that vitamin C has the potential to fight cancer when used in high dosages. The study confirms earlier research findings published in numerous scientific cancer journals by scientists from the Dr. Rath Research Institute.
The institute's research documents that vitamin C, when used in combination with the amino acids L-lysine and L-proline and a polyphenol fraction of green tea known as Epigallocatechin Gallate (EGCG), could not only kill cancer cells, but limit tumor growth, its infiltration by blood vessels (angiogenesis), and completely stop the invasion and spread of more than two dozen cancer cell types. While the NIH study showed a 50 percent decrease in survival of cancer cells exposed to high doses of vitamin C in five out of nine cancer cell types, the combination of nutrients used by Rath's group was effective not only in eliminating cancer cells, but in arresting cancer cell tissue invasion -- a hallmark of metastasis responsible for 90 percent of deaths from cancer. Today, there are no effective measures to stop cancer metastasis.
Dr. Matthias Rath, founder of the Dr. Rath Research Institute, said, "The use of lysine, an amino acid, in combination with ascorbic vitamin C addresses common pathomechanisms of cancer, will lead to a breakthrough in the control of many forms of cancer and other diseases." Dr. Rath first published his concept of the natural control of cancer in the Journal of Applied Nutrition in 1992.
Research that confirmed Dr. Rath's approach was publicized in an advertisement in USA Today on March 8, 2002. Further research was presented at the 19th Annual Miami Breast Cancer Conference in February of 2002; at the American Association of Cancer Research Special Conference in Cancer Research in South Carolina in October of 2002; at many other national and international conferences; and in many publications. The most recent findings can be found at the Breast Cancer Research Web site at http://breast-cancer-research.com/content/7/3/R291.
"By using nutrient synergy and defining correct biological targets, we could achieve superior physiological effects, which is not possible with a single nutrient therapy, even if applied at extreme doses," said Dr. Aleksandra Niedzwiecki, director of research at the institute.
The Dr. Rath Research Institute is calling for a radical change in the treatment of cancer, one that takes advantage of new natural approaches. Conventional approaches, such as chemotherapy and radiation, have been unsuccessful in reducing the high mortality rate of the disease, have contributed only to the accelerated cost of health care, and led to the development of new diseases that result from the side effects of these treatments.
The Dr. Rath Research Institute offers innovative, safe, effective, and natural solutions to cancer. To learn more, visit www.drrathresearch.org.